May 25, 2022
Loading...
You are here:  Home  >  'Xgeva'
Latest

Amgen closes deal for $2.8B stake in oncology firm BeiGene

By   /  Friday, January 10th, 2020  /  Latest news  /  Comments Off on Amgen closes deal for $2.8B stake in oncology firm BeiGene

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

New drugs boost profits at Amgen as two executives leave company

By   /  Friday, August 3rd, 2018  /  Earnings, East Ventura County, Health Care & Life Science, left, Tri-County Public Companies  /  Comments Off on New drugs boost profits at Amgen as two executives leave company

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen earnings per share up 20 percent due to higher product sales

By   /  Thursday, July 26th, 2018  /  Earnings, East Ventura County, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen earnings per share up 20 percent due to higher product sales

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

European Union approves Amgen’s Xgeva to treat multiple myeloma

By   /  Tuesday, April 3rd, 2018  /  Health Care & Life Science, Latest news, Technology, Tri-County Public Companies  /  Comments Off on European Union approves Amgen’s Xgeva to treat multiple myeloma

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen wins new FDA approval for cancer drug Xgeva

By   /  Friday, January 5th, 2018  /  East Ventura County, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen wins new FDA approval for cancer drug Xgeva

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Latest

Amgen asks FDA to consider new uses for Xgeva

By   /  Monday, June 19th, 2017  /  East Ventura County, Health Care & Life Science, Latest news, Tri-County Public Companies  /  Comments Off on Amgen asks FDA to consider new uses for Xgeva

Thousand Oaks-based biotech giant Amgen announced June 19 that the U.S. Food and Drug Administration has accepted a supplemental application for Xgeva (denosumab) that seeks to expand the currently approved indication for the prevention of fractures and other skeletal-related events in patients with bone metastases from solid tumors to include patients with multiple myeloma. “Multiple Read More →

Latest

Amgen reports revenue increase in second quarter earnings

By   /  Wednesday, July 27th, 2016  /  Earnings, Health Care & Life Science, Latest news, Tri-County Public Companies, West Ventura County  /  Comments Off on Amgen reports revenue increase in second quarter earnings

Updated on July 27 at 4 p.m.: Amgen reported a 6 percent increase in revenue and a 15 percent increase in earnings per share in its second quarter earnings released July 27. Revenues grew to $5.7 billion due to higher sales of the company’s drugs Enbrel, Prolia, Kyprolis and Xgeva, and operating income increased 15 Read More →